DK0648121T3 - - Google Patents

Info

Publication number
DK0648121T3
DK0648121T3 DK94917283.7T DK94917283T DK0648121T3 DK 0648121 T3 DK0648121 T3 DK 0648121T3 DK 94917283 T DK94917283 T DK 94917283T DK 0648121 T3 DK0648121 T3 DK 0648121T3
Authority
DK
Denmark
Prior art keywords
ring
infection
spiropiperidyl
ring system
rifamycin
Prior art date
Application number
DK94917283.7T
Other languages
Danish (da)
English (en)
Inventor
Jack S Remington
Fausto G Araujo
Original Assignee
Palo Alto Medical Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/203,539 external-priority patent/US5529994A/en
Application filed by Palo Alto Medical Found filed Critical Palo Alto Medical Found
Application granted granted Critical
Publication of DK0648121T3 publication Critical patent/DK0648121T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
DK94917283.7T 1993-05-05 1994-04-29 DK0648121T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5728893A 1993-05-05 1993-05-05
US08/203,539 US5529994A (en) 1993-05-05 1994-02-28 Treatment for toxoplasmosis

Publications (1)

Publication Number Publication Date
DK0648121T3 true DK0648121T3 (de) 1997-02-24

Family

ID=26736295

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917283.7T DK0648121T3 (de) 1993-05-05 1994-04-29

Country Status (14)

Country Link
US (5) US5670496A (de)
EP (1) EP0648121B1 (de)
JP (1) JPH07509003A (de)
AT (1) ATE143601T1 (de)
AU (1) AU669300B2 (de)
CA (1) CA2138643A1 (de)
DE (1) DE69400631T2 (de)
DK (1) DK0648121T3 (de)
ES (1) ES2095772T3 (de)
GR (1) GR3021828T3 (de)
IL (1) IL109543A (de)
NO (1) NO950030L (de)
RU (1) RU2121838C1 (de)
WO (1) WO1994025038A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
US6258532B1 (en) 1997-08-14 2001-07-10 Vanderbilt University Methods for in vitro susceptibility testing of chlamydia
US6579854B1 (en) 1996-08-14 2003-06-17 Vanderbilt University Diagnosis and management of infection caused by chlamydia
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
EP1166117A2 (de) * 1999-03-19 2002-01-02 Vanderbilt University Diagnose und behandlung multipler sklerose
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6858083B2 (en) * 2002-06-05 2005-02-22 Scimed Lifesystems, Inc. Apparatus and method for closed-loop control of RF generator for welding polymeric catheter components
US20030017985A1 (en) * 2002-07-02 2003-01-23 Taylor Gregory Alan Molecules that influence pathogen resistance
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
TW201434467A (zh) 2005-10-05 2014-09-16 Otsuka Pharma Co Ltd 抗結核治療藥物及含彼之套組
US7799885B2 (en) * 2005-11-30 2010-09-21 Corning Incorporated Photo or electron beam curable compositions
US20090054380A1 (en) * 2005-12-20 2009-02-26 Greenstein Robert J Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
FR2944014A1 (fr) 2009-04-06 2010-10-08 Univ Grenoble 1 Peptides cycliques a activite antiparasitaire
CN114601840A (zh) * 2020-12-08 2022-06-10 复旦大学附属中山医院 一种联合用药,用于治疗卡氏肺孢子虫肺炎
CN113230248A (zh) * 2021-06-18 2021-08-10 宁波大学 利卡灵-b及其组合物在制备治疗或预防弓形虫病药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644616A (en) * 1969-03-24 1972-02-22 Ciba Geigy Corp Synergistic composition of rifampicin and streptomycin
US4054663A (en) * 1974-12-23 1977-10-18 Sankyo Company Limited Pyridine derivatives and their use as anticoccidial agents
US4094982A (en) * 1975-05-15 1978-06-13 Sankyo Company Limited Pyridine sulfonamides and their use as anticoccidial agents
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
IT1135270B (it) * 1980-04-12 1986-08-20 Erba Farmitalia 3-amidino-ansamicine
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
DE3512194A1 (de) * 1985-04-03 1986-10-09 Hoechst Ag, 6230 Frankfurt Ein neues ansamycin-antibiotikum, ein mikrobielles verfahren zu seiner herstellung und seine verwendung als arzneimittel
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis

Also Published As

Publication number Publication date
EP0648121A1 (de) 1995-04-19
US5641769A (en) 1997-06-24
RU2121838C1 (ru) 1998-11-20
AU6905094A (en) 1994-11-21
IL109543A0 (en) 1994-08-26
CA2138643A1 (en) 1994-11-10
WO1994025038A1 (en) 1994-11-10
RU95105973A (ru) 1997-01-20
NO950030D0 (no) 1995-01-04
EP0648121B1 (de) 1996-10-02
US5648345A (en) 1997-07-15
NO950030L (no) 1995-01-04
IL109543A (en) 1998-06-15
AU669300B2 (en) 1996-05-30
US5665707A (en) 1997-09-09
DE69400631T2 (de) 1997-02-27
US5650405A (en) 1997-07-22
DE69400631D1 (de) 1996-11-07
ES2095772T3 (es) 1997-02-16
US5670496A (en) 1997-09-23
ATE143601T1 (de) 1996-10-15
JPH07509003A (ja) 1995-10-05
GR3021828T3 (en) 1997-02-28

Similar Documents

Publication Publication Date Title
DK0648121T3 (de)
AU653415B2 (en) Method of treating ocular inflammation
IL126339A (en) Taxol derivatives
MX9707732A (es) Compuestos triciclicos utiles en el tratamiento de desordenes proliferativos de celulas.
EP0935415A4 (de) Verfahren zum einbringen von verbindungen in eine zelle
SG48750A1 (en) Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
AU562646B2 (en) 1-alkyl-androsta-1, 4-diene-3, 17-diones
KR0166663B1 (en) Use of il-10 to prevent insulin-dependent diabetes mellitus
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ES2074946A1 (es) Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
CA2188871A1 (en) Method for Treating Psoriasis
AU7719491A (en) Therapeutic compound
AU654275B2 (en) Method for reducing emesis and nausea induced by the administration of an emesis-causing agent
EP0260790A3 (de) Verwendung von Pinacidil zur Behandlung von Inkontinenz
AU629032B2 (en) Letterpress for transferring and method of transferring by use of the letterpress for transferring
NZ336249A (en) parenteral composition of a dihydropolyprenol and a pharmaceutically acceptable oil
AU6112394A (en) Vinca alkaloids for the treatment of papillomavirus infection
CA2080040A1 (en) Methods for preventing mycobacterial infections by administration of rifabutin
IL115023A0 (en) Methods of reducing scarring in wound healing
UA66809C2 (uk) Спосіб лікування гіперглікемії похідною тіазолідиндіону
MY109685A (en) Method for treating hepatitis b carriers with minimal disease